Japan Rolls Out Three-Tiered Review System For Medical Devices
This article was originally published in PharmAsia News
Executive Summary
Japan is rolling out a new three-track medical device review system based on the novelty of the product, Japanese device reviewers said
You may also be interested in...
AdvaMed Wary Of Japan's Ability To Improve Incremental Product Review
Japan is in need of device industry investment, but without the incentive of data exclusivity, the government needs to counter existing disincentives, says AdvaMed CEO.
Drug Makers Say Japan's PMDA Drug Review Performance Improving
Japan's drug review body, the Pharmaceutical and Medical Device Agency, has significantly improved performance of the drug review process, demonstrated by shortened review times and higher satisfaction ratings, said the Office of Pharmaceutical Industry Research, a policy think tank under the industry trade association Japan Pharmaceutical Manufacturers Association
Reform In Japan: Reviewers And Fees Go Up; Will Approval Times Go Down?
U.S. device manufacturers hope an "action program" adopted by the Japanese government Dec. 17 and tied to increased industry user fees will significantly speed device approval times there